Medication Recommendations for Insomnia in Elderly Patients

Introduction to Insomnia Treatment

• The American Academy of Sleep Medicine recommends low-dose doxepin (3-6 mg) as a first-line treatment option for sleep maintenance insomnia in elderly patients, due to its efficacy and safety profile 1, 2
• For sleep onset insomnia, ramelteon (8 mg) is recommended as a melatonin receptor agonist with minimal drug interaction potential and no abuse liability, making it safer in elderly patients 1, 2

Medication Selection and Dosing

• The American Academy of Sleep Medicine suggests suvorexant (10-20 mg) as an orexin receptor antagonist for sleep maintenance, reducing wake time after sleep onset by 16-28 minutes 1, 2, 4
• Zolpidem should be used at a reduced dose of 5 mg in elderly patients due to increased risk of falls and cognitive impairment 2
• Doxepin should be initiated at 3 mg and not exceed 6 mg in elderly patients, due to its potential for adverse effects 1, 2

Medications to Avoid

• The American Academy of Sleep Medicine advises against the use of additional antihistamines, such as diphenhydramine, in elderly patients due to increased anticholinergic burden and risk of delirium and cognitive impairment 1, 2
• Trazodone is not recommended for insomnia treatment in elderly patients due to its significant fall risk and lack of efficacy 1, 2, 4

Safety Monitoring and Follow-Up

• Regular monitoring every 2-4 weeks is necessary to assess the effectiveness and safety of insomnia medications in elderly patients, including the risk of falls, cognitive impairment, and drug interactions 3, 5
• The American Academy of Sleep Medicine recommends reassessing patients after 7-10 days of treatment and planning for medication tapering to use the lowest effective dose for the shortest duration possible 3, 4, 5